Nutraceuticals, get it right from the start
The Indian supplements market is anticipated to soar to nearly fifty-seven billion dollars by twenty thirty, driven by heightened consumer awareness and the prevalence of lifestyle diseases. Major consumer goods firms are rushing to acquire scient...

But unlike chemistry-based prescription drugs that fall under the scrutiny of CDSCO and state drug control authorities, 'not for medicinal use' nutraceuticals fall under the FSSAI's purview. The latter's less regulatory strictness has catalysed a long list of brands, including those focused on emerging sub-categories like 'mushroom-based supplements'. Developed markets in the US and Europe, with streamlined supply chains and sales channels, offer natural checks and balances across stakeholders. India needs to stay sharp with a specialised regulator, greater emphasis on product registration, permissible ingredients, claims and quality standards. Ayurvedic ingredients, formulations and IP could add another layer of complexity, especially regarding heavy-metal contamination, making robust raw material-testing and finished-product efficacy critical for credible players.
Adulteration of nutraceutical products through inclusion of undeclared pharma ingredients has become a global headache. Such products can contain pharmacologically-active substances without appropriate disclosure, creating significant consumer-safety as well as regulatory and reputational risks. India needs to nip this in the bud that's already bursting at the seams.
The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.